- Home
- WFRD vs TMDX Comparison
WFRD vs TMDX Comparison
Compare WFRD & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFRD
- TMDX
- Stock Information
- Founded
- WFRD 1941
- TMDX 1998
- Country
- WFRD United States
- TMDX United States
- Employees
- WFRD N/A
- TMDX N/A
- Industry
- WFRD Metal Fabrications
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WFRD Industrials
- TMDX Health Care
- Exchange
- WFRD Nasdaq
- TMDX Nasdaq
- Market Cap
- WFRD 4.1B
- TMDX 4.8B
- IPO Year
- WFRD N/A
- TMDX 2019
- Fundamental
- Price
- WFRD $56.32
- TMDX $127.20
- Analyst Decision
- WFRD Strong Buy
- TMDX Buy
- Analyst Count
- WFRD 7
- TMDX 10
- Target Price
- WFRD $97.57
- TMDX $129.11
- AVG Volume (30 Days)
- WFRD 1.1M
- TMDX 1.4M
- Earning Date
- WFRD 07-22-2025
- TMDX 07-30-2025
- Dividend Yield
- WFRD 1.77%
- TMDX N/A
- EPS Growth
- WFRD N/A
- TMDX 2163.11
- EPS
- WFRD 6.50
- TMDX 2.02
- Revenue
- WFRD $5,147,000,000.00
- TMDX $531,292,000.00
- Revenue This Year
- WFRD N/A
- TMDX $34.57
- Revenue Next Year
- WFRD $0.95
- TMDX $20.83
- P/E Ratio
- WFRD $8.69
- TMDX $64.33
- Revenue Growth
- WFRD N/A
- TMDX 48.09
- 52 Week Low
- WFRD $36.74
- TMDX $55.00
- 52 Week High
- WFRD $111.23
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- WFRD 52.21
- TMDX 57.43
- Support Level
- WFRD $55.14
- TMDX $126.78
- Resistance Level
- WFRD $57.92
- TMDX $133.54
- Average True Range (ATR)
- WFRD 2.32
- TMDX 6.45
- MACD
- WFRD -0.21
- TMDX 2.03
- Stochastic Oscillator
- WFRD 52.85
- TMDX 81.62
About WFRD Weatherford International plc
Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.